Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO
Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.
📰 Original Source
Read full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.